269 related articles for article (PubMed ID: 7622005)
1. Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance.
de Souza CJ; Yu JH; Robinson DD; Ulrich RG; Meglasson MD
Diabetes; 1995 Aug; 44(8):984-91. PubMed ID: 7622005
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes.
Hirshman MF; Fagnant PM; Horton ED; King PA; Horton ES
Biochem Biophys Res Commun; 1995 Mar; 208(2):835-45. PubMed ID: 7695642
[TBL] [Abstract][Full Text] [Related]
3. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
[TBL] [Abstract][Full Text] [Related]
4. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.
Nolan CJ; Leahy JL; Delghingaro-Augusto V; Moibi J; Soni K; Peyot ML; Fortier M; Guay C; Lamontagne J; Barbeau A; Przybytkowski E; Joly E; Masiello P; Wang S; Mitchell GA; Prentki M
Diabetologia; 2006 Sep; 49(9):2120-30. PubMed ID: 16868750
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats.
Ishida H; Kato S; Nishimura M; Mizuno N; Fujimoto S; Mukai E; Kajikawa M; Yamada Y; Odaka H; Ikeda H; Seino Y
Horm Metab Res; 1998 Nov; 30(11):673-8. PubMed ID: 9918384
[TBL] [Abstract][Full Text] [Related]
6. A low protein diet lowers islet insulin secretion but does not alter hyperinsulinemia in obese Zucker (fa/fa) rats.
Tse EO; Gregoire FM; Magrum LJ; Johnson PR; Stern JS
J Nutr; 1995 Jul; 125(7):1923-9. PubMed ID: 7616309
[TBL] [Abstract][Full Text] [Related]
7. Glucose refractoriness of beta-cells from fed fa/fa rats is ameliorated by nonesterified fatty acids.
Chan CB; Surette JJ
Can J Physiol Pharmacol; 1999 Dec; 77(12):934-42. PubMed ID: 10606439
[TBL] [Abstract][Full Text] [Related]
8. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
9. In vivo administration of the C16:0 fatty acid isoform of sulfatide increases pancreatic sulfatide and enhances glucose-stimulated insulin secretion in Zucker fatty (fa/fa) rats.
Blomqvist M; Carrier M; Andrews T; Pettersson K; Månsson JE; Rynmark BM; Fredman P; Buschard K
Diabetes Metab Res Rev; 2005; 21(2):158-66. PubMed ID: 15580649
[TBL] [Abstract][Full Text] [Related]
10. Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat.
Ahrén B; Magrum LJ; Havel PJ; Greene SF; Phinney SD; Johnson PR; Stern JS
Obes Res; 2000 Sep; 8(6):475-80. PubMed ID: 11011915
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between islet alpha cell insulin resistance and inflammatory pathway activation and its mechanism].
DU RQ; Li HL; Yang WY; Xiao JZ; Wang B; Lou DJ; Bai XP; Pan L
Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):661-5. PubMed ID: 17967239
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice.
Kawasaki F; Matsuda M; Kanda Y; Inoue H; Kaku K
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E510-8. PubMed ID: 15522998
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats.
Hayakawa T; Shiraki T; Morimoto T; Shii K; Ikeda H
Biochem Biophys Res Commun; 1996 Jun; 223(2):439-44. PubMed ID: 8670300
[TBL] [Abstract][Full Text] [Related]
14. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
Sugiyama Y; Shimura Y; Ikeda H
Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
[TBL] [Abstract][Full Text] [Related]
15. Evidence for defective glucose sensing by islets of fa/fa obese Zucker rats.
Chan CB; MacPhail RM; Mitton K
Can J Physiol Pharmacol; 1993 Jan; 71(1):34-9. PubMed ID: 8513432
[TBL] [Abstract][Full Text] [Related]
16. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
[TBL] [Abstract][Full Text] [Related]
17. The effects of high-fat diet on exercise-induced changes in metabolic parameters in Zucker fa/fa rats.
Kibenge MT; Chan CB
Metabolism; 2002 Jun; 51(6):708-15. PubMed ID: 12037723
[TBL] [Abstract][Full Text] [Related]
18. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
[TBL] [Abstract][Full Text] [Related]
19. KATP channel-dependent and -independent pathways of insulin secretion in isolated islets from fa/fa Zucker rats.
Chan CB; MacPhail RM
Biochem Cell Biol; 1996; 74(3):403-10. PubMed ID: 8883846
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.
Hallakou S; Foufelle F; Doaré L; Kergoat M; Ferré P
Diabetologia; 1998 Aug; 41(8):963-8. PubMed ID: 9726600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
